Jpmorgan Chase & Co »

Unicycive Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $78k 10k 7.70

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Microsoft Corp Common (MSFT)
Alphabet Common (GOOG)
Amazon Common (AMZN)
Broadcom Common (AVGO)
State Street Spdr S&p 500 Etf Fund (SPY)
Alphabet Common (GOOGL)
Micron Technology Common (MU)
Meta Platforms Common (META)
Advanced Micro Devices Common (AMD)
Lam Research Corp Common (LRCX)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Eli Lilly & Co Common (LLY)

View all positions for Jpmorgan Chase & Co

Top funds holding Unicycive Therapeutics

BlackRock
Nantahala Capital Management
Diadema Partners
Vanguard Capital Management
Octagon Capital Advisors
Susquehanna International
Geode Capital Management
Vivo Capital
Marshall Wace
Caption Management
Logos Global Management
Diametric Capital
J. Goldman & Co
Citadel Advisors
Millennium Management

View all funds holding Unicycive Therapeutics